Ferrante M - Search Results

1

The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.

Marchal L, D'Haens G, Van Assche G, Vermeire S, Noman M, Ferrante M, Hiele M, Bueno De Mesquita M, D'Hoore A, Penninckx F, Rutgeerts P. Marchal L, et al. Among authors: ferrante m. Aliment Pharmacol Ther. 2004 Apr 1;19(7):749-54. doi: 10.1111/j.1365-2036.2004.01904.x. Aliment Pharmacol Ther. 2004. PMID: 15043515 Clinical Trial.

2

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.

Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Hlavaty T, et al. Among authors: ferrante m. Aliment Pharmacol Ther. 2005 Oct 1;22(7):613-26. doi: 10.1111/j.1365-2036.2005.02635.x. Aliment Pharmacol Ther. 2005. PMID: 16181301

3

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Among authors: ferrante m. Gut. 2009 Apr;58(4):492-500. doi: 10.1136/gut.2008.155812. Epub 2008 Oct 2. Gut. 2009. PMID: 18832518 Clinical Trial.

4

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.

Fidder H, Schnitzler F, Ferrante M, Noman M, Katsanos K, Segaert S, Henckaerts L, Van Assche G, Vermeire S, Rutgeerts P. Fidder H, et al. Among authors: ferrante m. Gut. 2009 Apr;58(4):501-8. doi: 10.1136/gut.2008.163642. Epub 2008 Oct 2. Gut. 2009. PMID: 18832524

5

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.

Ferrante M, D'Hoore A, Vermeire S, Declerck S, Noman M, Van Assche G, Hoffman I, Rutgeerts P, Penninckx F. Ferrante M, et al. Inflamm Bowel Dis. 2009 Jul;15(7):1062-70. doi: 10.1002/ibd.20863. Inflamm Bowel Dis. 2009. PMID: 19161179

6

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

Arijs I, Li K, Toedter G, Quintens R, Van Lommel L, Van Steen K, Leemans P, De Hertogh G, Lemaire K, Ferrante M, Schnitzler F, Thorrez L, Ma K, Song XY, Marano C, Van Assche G, Vermeire S, Geboes K, Schuit F, Baribaud F, Rutgeerts P. Arijs I, et al. Among authors: ferrante m. Gut. 2009 Dec;58(12):1612-9. doi: 10.1136/gut.2009.178665. Epub 2009 Aug 20. Gut. 2009. PMID: 19700435 Free article. Clinical Trial.

7

Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in Caucasians.

Bentley RW, Cleynen I, Gearry RB, Barclay ML, Rutgeerts P, Merriman TR, Ferrante M, Roberts RL, Vermeire S. Bentley RW, et al. Among authors: ferrante m. Genes Immun. 2010 Sep;11(6):509-14. doi: 10.1038/gene.2010.15. Epub 2010 May 6. Genes Immun. 2010. PMID: 20445566

8

Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.

Márquez L, Shen C, Cleynen I, De Hertogh G, Van Steen K, Machiels K, Perrier C, Ballet V, Organe S, Ferrante M, Henckaerts L, Galicia G, Rutgeerts P, Ceuppens JL, Vermeire S. Márquez L, et al. Among authors: ferrante m. Gut. 2012 Apr;61(4):528-34. doi: 10.1136/gut.2011.240978. Epub 2011 Jun 27. Gut. 2012. PMID: 21708824

9

Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.

Van Assche G, Ferrante M, Vermeire S, Noman M, Rans K, Van der Biest L, Penninckx F, Wolthuis A, Rutgeerts P, D'Hoore A. Van Assche G, et al. Among authors: ferrante m. Colorectal Dis. 2012 Apr;14(4):e181-6. doi: 10.1111/j.1463-1318.2011.02838.x. Colorectal Dis. 2012. PMID: 21951549 Clinical Trial.

10

Letter: dry blood spots for anti-TNF treatment monitoring in IBD.

Vande Casteele N, Brecx S, Declerck P, Ferrante M, Rutgeerts P, Vermeire S, Gils A. Vande Casteele N, et al. Among authors: ferrante m. Aliment Pharmacol Ther. 2013 May;37(10):1024-5. doi: 10.1111/apt.12283. Aliment Pharmacol Ther. 2013. PMID: 23590542 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

991 results

Search Page

Filters